167 related articles for article (PubMed ID: 33494416)
41. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
[TBL] [Abstract][Full Text] [Related]
42. Improved radiosynthesis and preliminary in vivo evaluation of the
Stéen EJL; Jørgensen JT; Petersen IN; Nørregaard K; Lehel S; Shalgunov V; Birke A; Edem PE; L'Estrade ET; Hansen HD; Villadsen J; Erlandsson M; Ohlsson T; Yazdani A; Valliant JF; Kristensen JL; Barz M; Knudsen GM; Kjær A; Herth MM
Bioorg Med Chem Lett; 2019 Apr; 29(8):986-990. PubMed ID: 30795854
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System.
Edelmann MR; Bredack C; Belli S; Mohr P; Imhoff MP; Reggiani F; Kusznir EA; Rufer AC; Holt DP; Valentine H; Wong DF; Dannals RF; Honer M; Gobbi LC
Bioconjug Chem; 2023 Oct; 34(10):1882-1893. PubMed ID: 37710950
[TBL] [Abstract][Full Text] [Related]
44. Curative Multicycle Radioimmunotherapy Monitored by Quantitative SPECT/CT-Based Theranostics, Using Bispecific Antibody Pretargeting Strategy in Colorectal Cancer.
Cheal SM; Fung EK; Patel M; Xu H; Guo HF; Zanzonico PB; Monette S; Wittrup KD; Cheung NV; Larson SM
J Nucl Med; 2017 Nov; 58(11):1735-1742. PubMed ID: 28705917
[TBL] [Abstract][Full Text] [Related]
45. Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter,
Shalgunov V; Engudar G; Bohrmann L; Wharton L; Maskell K; Johann K; Barz M; Schaffer P; Herth MM; Radchenko V
Nucl Med Biol; 2022; 104-105():11-21. PubMed ID: 34839209
[TBL] [Abstract][Full Text] [Related]
46.
Stéen EJL; Jørgensen JT; Johann K; Nørregaard K; Sohr B; Svatunek D; Birke A; Shalgunov V; Edem PE; Rossin R; Seidl C; Schmid F; Robillard MS; Kristensen JL; Mikula H; Barz M; Kjær A; Herth MM
ACS Nano; 2020 Jan; 14(1):568-584. PubMed ID: 31820928
[TBL] [Abstract][Full Text] [Related]
47. Investigation of Copper-64-Based Host-Guest Chemistry Pretargeted Positron Emission Tomography.
Jallinoja VIJ; Carney BD; Bhatt K; Abbriano CH; Schlyer DJ; Yazaki PJ; Houghton JL
Mol Pharm; 2022 Jul; 19(7):2268-2278. PubMed ID: 35700402
[TBL] [Abstract][Full Text] [Related]
48. Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.
Reiner T; Lewis JS; Zeglis BM
J Vis Exp; 2015 Feb; (96):e52335. PubMed ID: 25742199
[TBL] [Abstract][Full Text] [Related]
49. Preclinical Evaluation of a Novel
Ruivo E; Elvas F; Adhikari K; Vangestel C; Van Haesendonck G; Lemière F; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
ACS Omega; 2020 Mar; 5(9):4449-4456. PubMed ID: 32175492
[TBL] [Abstract][Full Text] [Related]
50. Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate.
Cook BE; Adumeau P; Membreno R; Carnazza KE; Brand C; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
Bioconjug Chem; 2016 Aug; 27(8):1789-95. PubMed ID: 27356886
[TBL] [Abstract][Full Text] [Related]
51. Design and Preclinical Evaluation of an Albumin-Binding PSMA Ligand for
Umbricht CA; Benešová M; Hasler R; Schibli R; van der Meulen NP; Müller C
Mol Pharm; 2018 Dec; 15(12):5556-5564. PubMed ID: 30376344
[TBL] [Abstract][Full Text] [Related]
52. Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.
McBride WJ; Zanzonico P; Sharkey RM; Norén C; Karacay H; Rossi EA; Losman MJ; Brard PY; Chang CH; Larson SM; Goldenberg DM
J Nucl Med; 2006 Oct; 47(10):1678-88. PubMed ID: 17015905
[TBL] [Abstract][Full Text] [Related]
53. Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
Subbiah K; Hamlin DK; Pagel JM; Wilbur DS; Meyer DL; Axworthy DB; Mallett RW; Theodore LJ; Stayton PS; Press OW
J Nucl Med; 2003 Mar; 44(3):437-45. PubMed ID: 12621012
[TBL] [Abstract][Full Text] [Related]
54. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule.
Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z
Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877
[TBL] [Abstract][Full Text] [Related]
55. Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
Ruggiero A; Villa CH; Holland JP; Sprinkle SR; May C; Lewis JS; Scheinberg DA; McDevitt MR
Int J Nanomedicine; 2010 Oct; 5():783-802. PubMed ID: 21042424
[TBL] [Abstract][Full Text] [Related]
56. Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity ⁸⁶Y- or ¹⁷⁷Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
Cheal SM; Xu H; Guo HF; Lee SG; Punzalan B; Chalasani S; Fung EK; Jungbluth A; Zanzonico PB; Carrasquillo JA; O'Donoghue J; Smith-Jones PM; Wittrup KD; Cheung NV; Larson SM
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):925-937. PubMed ID: 26596724
[TBL] [Abstract][Full Text] [Related]
57. Development of the First Tritiated Tetrazine: Facilitating Tritiation of Proteins.
Radjani Bidesi NS; Battisti UM; Lopes van de Broek S; Shalgunov V; Dall AM; Bøggild Kristensen J; Sehlin D; Syvänen S; Moos Knudsen G; Herth MM
Chembiochem; 2022 Dec; 23(23):e202200539. PubMed ID: 36333105
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[
Shalgunov V; van den Broek SL; Andersen IV; Raval NR; Schäfer G; Barz M; Herth MM; Battisti UM
Nucl Med Biol; 2024; 128-129():108877. PubMed ID: 38232579
[TBL] [Abstract][Full Text] [Related]
59. Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma.
Cheal SM; Xu H; Guo HF; Patel M; Punzalan B; Fung EK; Lee SG; Bell M; Singh M; Jungbluth AA; Zanzonico PB; Piersigilli A; Larson SM; Cheung NV
Theranostics; 2018; 8(18):5106-5125. PubMed ID: 30429889
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
